Announcement PDF 605 page 1/2 15July 2001 Form605 Corporations Act 2001 Section 671B Notice of ceasing to be a substantial holder To CompanyName/Scheme RACE ONCOLOGY LIMITED ACN/ARSN 149 318 749 1. Details of substantial holder(1) Name PETER LAURENCE MOLLOY ACN/ARSN (if applicable) The holder ceased to be a substantial holder on 12 July 2019 The previous notice was given to the company on The previous notice was dated 24 December 2018 24 December 2018 2. Changes in relevant interests Particulars of each change in, or changein the nature of, a relevant interest (2)of the substantial holder or an associate(3 ) inviting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows: Personwhose relevant interest changed Date of change Nature of change(4) 08/02/2019 Peter Molloy In specie distribution of shares by Update Pharma Inc, a company in which Peter Molloy held a minority interest 12/07/2019 Peter Molloy Dilution due to conversion of performance shares Considera tion given in relation to Nil N/A Class(6)and number of securities affected 26,411 FPO Person's votes affected 26,411 4,305,004 FPO 4,305,004 3. Changes in association The persons who have become associates (3)of, ceasedto be associates of, or have changedthe nature of their association(7) with, the substantial holder in relation to voting interests in the company or scheme are as follows: Name and ACN/ARSN (if applicable) Nature of association 4. Addresses The addressesof persons named in this form are as follows: Name Address Peter Laurence Molloy PO Box 301, Creswick VIC 3363 Signature print name sign here Peter Molloy capacity Personal / 2019 / 12 July date 605 page 2/2 15July 2001 DIRECTIONS (1) If there area number of substantial holders withsimilar or relatedrelevant interests (eg. a corporationandits relatedc orporations, or themanager andtrusteeof an equity trust), thenamescouldbeincludedinanannexure to theform. If therelevant interestsof agroupof personsareess entiallysimilar, theymaybereferredto throughout the formasa specifically namedgroupif themembership of eachgroup, with thenamesandaddressesof members isc learly set out in paragraph4 of the form. (2) See thedefinitionof "relevant interest" in sections608and671B(7)of theCorporationsAct 2001. (3) See thedefinitionof "associate" in section9 of theCorporationsAct 2001. (4) Includedetailsof: (a) anyrelevant agreement or other circumstancesbecauseof which thechangein relevant interest occurred. If subsection671B (4)applies, a copyof any document settingout the termsof anyrelevant agreement, anda statement by thepersongiving full andaccurate details of any contract, scheme or arrangement, must accompanythis form, together witha writtenstatement certifyingthiscontract, schemeor arrangement; and (b) anyqualificationof thepower of apersontoexercise, control theexerciseof, or influencetheexerciseof, thevotingpo wersor disposal of thesecuritiesto whichtherelevant interest relates(indicatingclearly theparticular securitiestowhichthequalificationapplies). See thedefinitionof "relevant agreement" in section9 of theCorporationsAct 2001. (5) Detailsof theconsiderationmust includeanyandall benefits,moneyandother, that anypersonfromwhoma relevant intere st wasacquiredhas, ormay, become entitledto receivein relationto that acquisition. Detailsmust beincludedevenif thebenefit isconditional onthehappen ingor not of acontingency. Detailsmust be includedof anybenefit paidonbehalf of thesubstantial holder or itsassociate in relationto theacquisitions, evenif they arenot paiddirectly to thepersonfrom whom therelevant interest wasacquired. (6) Thevotingsharesof acompanyconstituteoneclassunlessdividedintoseparateclasses. (7) Givedetails, if appropriate, of thepresent associationandanychangein that associationsincethelast substantial holdi ngnotice. 605GUIDE page1/1 13 March2000 GUIDE This guide does not form part of the prescribed form and is included by ASIC to assist you in completing and lodging form 605. Signature This form must be signed by either a director or a secretary of the substantial holder. Lodging period Nil Lodging Fee Nil Other forms to be completed Nil Additionalinformation (a) If additional space is required to complete a question, the information may be included on a separate piece of paper annexed to the form. (b) This notice must be given to a listed company, or the responsible entity for a listed managed investment scheme. A copy of this notice must also be given to each relevant securities exchange. (c) The person must give a copy of this notice: (i) within 2 business days after they become aware of the information; or (ii) by 9.30 am on the next trading day of the relevant securities exchange after they become aware of the information if: (A) a takeover bid is made for voting shares in the company or voting interests in the scheme; and (B) the person becomes aware of the information during the bid period. Annexures To make any annexure conform to the regulations, you must 1 use A4 size paper of white or light pastel colour with a margin of at least 10mm on all sides 2 show the corporation name and ACN or ARBN 3 number the pages consecutively 4 print or type in BLOCK letters in dark blue or black ink so that the document is clearly legible when photocopied 5 identify the annexure with a mark such as A, B, C, etc 6 endorse the annexure with the words: This is annexure (mark) of (number) pages referred to in form (form number and title) 7 sign and date the annexure The annexure must be signed by the same person(s) who signed the form. Information in this guide is intended as a guide only. Please consult your accountant or solicitor for further advice.